Methyl gallate (2) showed activity against the sensible strain M. tuberculosis H37Rv with MIC of 50 μg/ml, respectively. The (2S)-Naringenin 7-O-β-galloylglucopyranoside (3) showed activity against multidrug resistant M. tuberculosis G122 with MIC of 50 μg/ml by MABA
Canthin-6-one (6), 8-hydroxy-canthin-6-one (7), and 5(ζ)-hydroxy-octadeca-6(E)-8(Z)-dienioc acid (8) with MICs in the range 8–32 μg/ml against a panel of fast-growing Mycobacterium species by dilution method
Betulin (12), betulinic acid (13), and betulone (14) with MIC of 12.5, 84, and 57 μ g/ml against M. tuberculosis H37Ra by the microplate resazurin assay
(14β, 24E)-3-oxolanosta-7,24-dien-26-oic acid (16) and (14β,24E)-3-hydroxylanosta-7,24-dien-26-oic acid (17) with MIC of 64 and 32 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by Bactec 460-TB apparatus
Falcarindiol (20), 9Z,17-octadecadiene-12,14-diyne-1,11,16-triol,1-acetate (21), and oplopandiol (22) with MIC of 26.7, 25.3, and 50.2 μg/ml, respectively, against M. tuberculosis H37Rv by MABA
One pimarane-type diterpene named pimaric acid (23) and two abietane-type diterpenes named 9a,13a-epidioxyabiet-8 (14)-en-18-oic acid (24) and 15-hydroxydehydroabietic acid (25) with MIC of 50 μg/ml, respectively, against M. tuberculosis H37Ra by MABA
(3R)-falcarinol (26) and (3R, 9R, 10S)-panaxydol (27) with MICs of 25.6 μM and 36.0 μM and IC50fs of 15.3 μM and 23.5 μM against M. tuberculosis H37Ra by microplate resazurin assay
5-alkylresorcinols (28), 5-(8Z-heptadecenyl) resorcinol (29), and 5-(8Z-pentadecenyl) resorcinol (30) with MIC of 34.4 and79.2 μM against M. tuberculosis H37Rv (ATCC 27294) by MABA assay, respectively
Quercetin 37 di-O methyl 3-sulphate (31) and kaempferol 7-O methyl 3-sulphate (32) against M. tuberculosis H37Rv with MIC values of 25 μg/ml, respectively, by MABA
(E)-2-(methyl (phenyl) amino) ethyl 2-(2-hydroxyundecanamido)-7 (33), 11-dimethyl-3-oxotetradec-4-enoate (34), and compound 1 inhibit mycobacterial biofilm formation, disperse the preformed biofilms, and disrupt the mature biofilms at concentration of 4, 8, and 32 μg/ml, respectively
Licarin A (36), licarin B (37), and eupomatenoid-7 (38) with MIC of 3.12-12.5 μg/ml against M. tuberculosis strains: H37Rv, four mono-resistant H37Rv variants and 12 clinical MDR isolates by MABA
Isoimperatorin (39), osthol (40), suberosin (41), and 8-methoxypsoralen (42) with MIC of 64, 32, 16, and 128 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by MABA
Azorellanol (47) and 17-acetoxy-13-alpha-hydroxy-azorellane (48) showed the strongest activity, with MIC of 12.5 μg/ml against both strains (M. tuberculosis H37Rv (ATTC 27294) and a clinical isolate CIBIN/UMF15:99) by MABA
Bauhinoxepins A (=3,3,5-trimethy lbenzo[b] pyrano[g] benzoxepin-6,11-diol) (50) and B (=6-methoxy-7-methyl-2-(3-methylbut-2-enyl)dibenzo[b,f]oxepine-1,8-diol (51) against M. tuberculosis H37Rv with MIC of 6.25 and 12.5 μg/ml, respectively, by MABA
Three new epoxyfuranoid lignans, 4a,5a-epoxybeilschmin A (54) and B (55), and beilschmin D (56), together with known beilschmin A (57) and B (58) with MICs of 30, 40, 50, 2.5, and 7.5 μg/ml, respectively, against M. tuberculosis 90-211378 by proportion method on agar
24-Hydroperoxycycloart-25-en-3β-ol (59) and 25-hydroperoxycycloart-23-en-3β-ol (60) with MIC of 12.5 and 25 μg/ml against drug-resistant clinical isolates by MABA
Alkaloids 6-methoxydihydrochelirubine (61) and 6-methoxydihydrocheleritrine (62) against M. tuberculosis H37Rv and MDR tuberculosis with MIC of 12.5-50 μg/ml by MABA
6 Beta-benzoyl-7 beta-hydroxyvouacapen-5 alpha-ol (63) and 6 beta-cinnamoyl-7beta-hydroxyvouacapen-5 alpha-ol (64) with MIC of 25 and 6.25 μg/ml against M. tuberculosis H37Ra by MABA
3-Deoxysappanchalcone (65) against both drug-susceptible and drug-resistant strains of M. tuberculosis at MIC50s of 3.125–12.5 μg/ml in culture broth and MIC50s of 6.25–12.5 μg/ml inside macrophages and pneumocytes
12-Deoxy-11,12-dihydro-seco-hinokiol methyl ester (68), callicarpic acid B (69), and alpha-tocopherol trimer B (70) with MICs ≤63.6 μM against M. tuberculosis H37Rv in vitro by MABA
Goyazensolide (72), centratherin (73), lychnophorolide B (74), isogoyazensolide (75), isocentratherin (76), 5-epi-isogoyazensolide (77), and 5-epi-isocentratherin (78) with MICs of 3.1, 3.1, 6.2, 1.5, 3.1, 3.1, and 3.1 μg/ml, against M. tuberculosis H37Rv, respectively, by MABA
1α-Acetoxy-6β, 9β-dibenzoyloxy-dihydro-b-agarofuran (79) with MIC value of 6.2 μg/ml against sensitive and resistant M. tuberculosis strains by MTT method
Maniladiol (81), 3-epilupeol (82), and 4,5a-epoxyhelianol (83) with MIC of 4 μg/ml, 4 μg/ml, and 6 μg/ml, respectively, against M. tuberculosis H37Rv by MABA
Ursolic acid (43) and cucurbitacin E 2-0-β-D-glucopyranoside (84) against M. tuberculosis H37Rv with MICs0f50 and 25 μg/ml, respectively, by BACTEC 460TB system
Both 5,8-dimethoxypsoralen (85) and palmitic acid (86) with the MIC of 25 μg/ml against M. tuberculosis H37Rv (ATCC 27294) and M. tuberculosis H10 by MABA
Dentatin (87), nor-dentatin (88), clausenidin (89), 3-formylcarbazole(90), mukonal (91), 3-methoxycarbonylcarbazole (92), 2-hydroxy-3-formyl-7-methoxycarbazole (93), and clauszoline J (94) with MIC of 50, 100, 200, 100, 200, 50, 100, and 100 μg/ml against M. tuberculosis H37Ra by MABA
Oleanane triterpenoid aegicerin (95) with MIC values ranged between 1.6 and 3.12 μg/ml against 37 different sensitive and resistant MTB strains by thiazolyl blue tetrazolium bromide method
16-Dien-9,15-dione (102), ent-8,9-seco-8,14-epoxy-7R-hydroxy-11â-acetoxy-16-kauren-9,15-dione (103), ent-8,9-seco-7R-hydroxy-11â-acetoxykaura-8 (14) with MICs of 25.0, 6.25, and 6.25 μg/ml, respectively, and possessed antimalarial activity with IC50 ranges of 1.0-2.8 μg/ml against M. tuberculosis H37Ra by MABA
3-Methoxy-(3,4-dihydro-3,4-diacetoxy)-2,2-dimethylpyrano-(7,8 : 5,6)-flavone (108), 3,4-methylenedioxy-10-methoxy-7-oxo[2]benzopyrano[4,3-b]benzopyran (109), karanjachromene (110), and pinnatin (111) against M. tuberculosis H37Ra with MICs of 25, 6.25, 12.5, and 12.5 μg/ml by MABA
Distemonanthoside (119), sitosterol 3-O- -d-glucopyranoside, 4-methoxygallic acid (118), and quercetin (121), against a clinical isolate strain of M. tuberculosis AC 45 with MIC ranged from 31.25 to 125 μg/ml by MABA
Engelharquinone (127), 3-methoxyjuglone (128), and (-)-4-hydroxy-1-tetralone (129) with MIC of 3.125, 3.125, and 6.25 μg/ml against M. tuberculosis 90-221387 and 0.2, 0.2, and 4.0 μg/ml against M. tuberculosis H37Rv, respectively, by agar proportion method
Khonklonginol A (130), B (131), H (132), and lupinifolinol (133), dehydrolupinifolinol (134), flemichin (135), eriosemaone A (136), and lupinifolin (137), with MICs of 25, 50, 25, 25, 12.5, 12.5, 12.5, and 12.5 μg/ml, respectively, against M. tuberculosis H37Ra by MABA
Isoflavonoidspasellidin (138) and erythobissin (139) with MICs, respectively, lying between 8 μg/ml and 25 μg/ml against MTB; 3-phenyl coumarin derivative indicanine (140) with MIC of 18.5 μg/ml against M. smegmatis by agar proportion method
Isoflavonoidspasellidin (138) and erythobissin (139) with MICs between 8 μg/ml and 25 μg/ml against M. tuberculosis H37Rv; 3-phenyl coumarin derivative indicanine (138) with MIC of 18.5 μg/ml against M. smegmatis by agar proportion method
Hydroxymyristic acid methylester (142) and a substituted pyrenyl ester (143), a sterol with MIC of 49.45 and 46.99 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by MABA
Ergosterol peroxide (147), cycloart-23-en-3β,25-diol (148), vanillin (149), and 4-hydroxybenzaldehyde (150) against M. tuberculosis H37Rv ATCC 27294 strain using two different systems: BACTEC 460TB (Bactec 460)
Exocarpic acid (E-octadeca-13-ene-9,11-diynoic-acid) (151) with MIC of 20 μg/ml against M. tuberculosis H37Ra (ATCC 25177) by the thiazolyl blue tetrazolium bromide method
Scopoletin (152), isobavachalcone (153) and (E)-1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(2,2-dimethyl-8-hydroxy-2H-benzopyran-6-yl)prop-2-en-1-one (154), copoletin (155), and umbelliferone (156) with MICs of 42, 18, 30, 42, and 58.3 μg/ml against M. tuberculosis H37Rv by the agar proportion method
Jaeschkeanadiol benzoate (teferidin) (157) and jaeschkeanadiol p-hydroxybenzoate (ferutinin) (158) with MIC values of 3.125 and 1.56 μg/ml against M. bovis BCG Pasteur 1173P2 and 0.69 and 2 μg/ml against M. tuberculosis H37Rv, respectively, by fluorescence assay
Amentoflavone (159) and 4-monomethoxy amentoflavone (160) with MIC of 0.6 ad 1.4 mg/ml against M. smegmatis (ATCC 1441), with the positive control isoniazid ( mg/ml) by tetrazolium violet indicator
6,6-Biapigenin hexamethylether (161), volkensiflavone hexamethylether (162), and hexamethylether of GB-1a (163) against M. tuberculosis H37Rv with inhibition of 96%, 95%, and 87% at 1.25 μg/ml by BACTEC 460TB
4-Prenyl-2-(3,7-dimethyl-2,6-octadienyl)-1,3,5,8-tetrahydroxyxanthone (164) with MIC of 8 μg/ml against M. tuberculosis H37Rv ATCC 27294 and M. tuberculosis clinical MTCS2 by MABA
Perforamone B (5-hydroxy-7-methoxy-2-methyl-8-(1-hydroxy-3-methyl-3-butenyl)chromone) (167) and D (2-hydroxymethylalloptaeroxylin) (168), peucin-7-methyl ether (169), and greveichromenol (170) with MICs of 25, 25, 50, and 50 μg/ml against M. tuberculosis H37Ra by MABA
2,4,6-Trihydroxy-3-prenylchalcone (171) and 4,6,5-trihydroxy-6,6-dimethyldihydropyrano-[2,3-2,3] chalcone (172) with MICs of 0.05 μg/ml against M. tuberculosis H37Rv by BACTEC radiometric method
(3R,8S)-Falcarindiol (173) and 6-isopentenyloxyisobergapten (174) with MICs of 24 μM and 167 μM and IC50s of 6 μM and 27 μM against M. tuberculosis H37Ra, respectively
Anthelminthicins A (176), B (177), C (178) (11-(cyclopent-1-en-1-yl)-11-oxoundecanoic acid, 2,3-dihydroxypropyl 9-[(R)-cyclopent-2-en-1-yl]nonanoate, 2,3-dihydroxypropyl 13-[(R)-cyclopent-2-en-1-yl]tridecanoate), and two known ones, namely, chaulmoogric acid (179) and ethyl chaulmoograte (180) with MIC of 5.54, 16.70, 4.38, 9.82, and 16.80 μM, respectively, by GFP-expressed M. tuberculosis H37Rv
Hyperenone A (181) against M. tuberculosis H37Rv and M. bovis BCG with MIC of 75 μg/ml and 100 μg/ml, respectively, by thiazolyl blue tetrazolium bromide method
3â,25-Epoxy-3R,21R-dihydroxy-22â-angeloyloxyolean-12-ene-28-oic acid (183), camaric acid (184), and rehmannic acid (185) with MICs of 64, 64, and 32 μM, respectively, against M. tuberculosis H37Rv by BACTEC 460 radiometric system
Isocupressic acid (186) and communic acid (187) displayed MICs of 78 μM and 31 μM against M. tuberculosis H37Ra, respectively, by microplate resazurin assay
Three pentacyclic triterpenoids of 3-acetoxy-22-(2-methyl-2Z-butenyloxy)-12-oleanen-28-oic acid (192), 3-hydroxy-22β-(2-methyl-2Z-butenoyloxy)-12-oleanen-28-oic acid (reduced lantadene A) (193), and oleanolic acid (194) with MIC of 50, 50, and 25 μg/ml against M. tuberculosis H37Rv by MABA
5,7-Dihydroxy-3-methoxy-2-(4-methox-yphenyl)-4H-chromen-4-one (195); 5,6,7-trihy-droxy-3-methoxy-2-(4-methoxyphenyl)-H-chromen-4-one (196); β,γ-dimethyl-,α,δ-bis(3,4-dihydroxyphenyl)butane (17) with MIC of 50 μg/ml, respectively, against M. tuberculosis H37Rv (ATCC 27294) by Bactec 460-TB apparatus
Falcarindiol (198) with MIC of 20 μg/ml and sesquiterpene alcohol a-prethapsenol (199) with MIC of 60 μg/ml against M. tuberculosis H37Rv by spot culture growth inhibition assay
Lavonesnevadensin (5,7-dihydroxy-6,8,4-trimethoxyflavone) (200) and isothymusin (6,7-dimethoxy-5,8,4-trihydroxyflavone) (201) against M. tuberculosis H37Ra by MABA
Litseakolide L (208) and N-trans-feruloylmethoxytyramine (209) with MIC values of 25 and 1.6 μg/ml, respectively, against M. tuberculosis H37Rv by agar proportion method
4-Methoxy-2-phenylquinoline (212) and 4-methoxy-2-(3,4-ethylenedioxy) phenyl quinoline (213) with MICs of 16 μg/ml, respectively, against M. tuberculosis H37Rv by BACTEC radiometric method
Micromolide ((−)-Z-9-octadecene-4-olide) (215) and five known alkaloids: lansine (216), 3-formylcarbazole (90), and 3-formyl-6-methoxycarbazole (217) with MIC of 1.5, 31.5, 14.3, 42.3, and 15.6 μg/ml, against M. tuberculosis H37Rv by MABA
1α-Acetoxy-2α-hydroxy-6β,9β,15-tribenzoyloxy-β-dihydroagarofuran (218), 2α-acetoxy-1α-hydroxy-6β,9β, 15-tribenzoyloxy-β-dihydroagarofuran (219), rbiculin G (220), and triptogelin G-2 (221) with MICs of 19.5, 15.8, 14.6, and 26 μM against M. tuberculosis 90-221387 by agar proportion method
15-Acetoxyorbiculin G (222), celahin C (223), salasol A (224), and 8-acetoxymutangin (225) with a MIC of 39.6 μM, 15 μM, 15 μM, and 10 μg/ml, respectively, against M. tuberculosis H37Rv by agar proportion method
E-Phytol (mixture of the two ketosteroids, stigmasta-4-en-3-one (226) and stigmasta-4-22-dien-3-one (227)) and the epidioxysterol campesta-5,7,22-trien-3β-ol (228) with MIC of 2.5 μg/ml and minus 2.0 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by the growth index
13-Hydroxy-mulin-11-en-20-oic-acid methyl ester (229), isomulinic acid n-propyl ester (230), and isomulinic acid n-butyl ester (231) with MIC of 6.25 μg/ml, respectively, against M. tuberculosis H37Rv (ATCC 27294) by MABA
Thymoquinone (TQ; 2-isopropyl-5-methyl-1, 4-benzoquinone) (117) with MIC of 12.5 μg/ml intracellular M. tuberculosis H37Rv and extensively drug-resistant tuberculosis (XDR-TB) 72 h postinfection in RAW 264.7 cells
5-Hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one(239) with MIC of 128 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by Bactec 460-TB apparatus
Pellitorine (241), guineensine (242), sarmentine (243), brachyamide B (244), 1-piperettyl pyrrolidine (245), sarmentosine (246), and 1-(3,4-methylenedioxyphenyl)-1E-tetradecene (247) with MIC values in the range of 25–200 μg/ml against M. tuberculosis H37Ra by MABA
Eupomatenoid-3 (248) and 5-(3-methyl-5-propylbenzofuran-2-yl) benzo[d][1,3]dioxole (249) against M. tuberculosis H37Rv by colorimetric resazurin microtiter assay plate
Synergism was observed in M. tuberculosis H37Rv and eight clinical isolates with eupomatenoid-5 (250) + rifampicin and in M. tuberculosis H37Rv and 17 clinical isolates with eupomatenoid-5+ ethambutol combinations
Abietanes 6β,7α-dihydroxyroyleanone (251), horminone, and 6,7-dehydroroyleanone (252) with MIC of 25 and 12.5 μg/ml, respectively, against M. tuberculosis H37Rv by MTT
7α-Acetoxy-6β-hydroxyroyleanone (MIC 0.0083 μM) (253) and 6,7-dehydroroyleanone (MIC 0.039 μM) (254) against M. tuberculosis H37Rv by thiazolyl blue tetrazolium bromide method
Potamogetonyde (262), potamogetonol (263), potamogetonin (264), and 15,16-epoxy-12-oxo-8 (17),13 (16),14-labdatrien-20,19-olide (265) with MIC of 50–100 μg/ml against M. tuberculosis H37Ra by MABA
a-Tocospiro A (266) and B (267), a-tocopherylquinone (268), and (E)-phytol (124) with MICs of 30, 50, 25, and 12.5 μg/ml against M. tuberculosis H37Rv by agar proportion method
Epigallocatechin-3-gallate (EGCG) (270) and quercetin (271) with MIC of MIC 32-256 μg/ml against nine M. tuberculosis isolates by thiazolyl blue tetrazolium bromide method
(benzophenones) Methyl (R)-3-[2-(3,4-dihydroxybenzoyl)-4,5-dihydroxyphenyl]-2-hydroxypropanoate (273) with MIC of 41.67 μg/ml against M. tuberculosis H37Rv by MABA
5-[(E)-2-(4-Acetoxyphenyl) ethenyl]-1,3-benzenediol(1a) (274) with MIC of 32 μg/ml against M. tuberculosis H37Rv (ATCC 27294) by Bactec 460-TB apparatus
Rumexneposide A (275), torachrysone (276), nepodin-8-O-b-D-glucopyranoside (277), torachrysone-8-O-b-D-glucopyranoside (278), and chrysophanol-8-O-b-D-glucopyranoside (279), which showed MICs of 20.7, 6.1, 26.6, 8.9, and 4.1 μM, respectively, by fluorescence assay
Tanshinone I (281), tanshinone IIA (282), and cryptotanshinone (283) with MIC in the range of 1.17–26.57 μg/ml against M. tuberculosis H37Rv by agar proportion method
Sapintoxin A (284), sapintoxin B (285), 12-(2¢-N-methylaminobenzoyl)-4R-deoxy-5,20-dihydroxyphorbol-13-acetate (286), and 12-(2-methylaminobenzoyl)-4-deoxyphorbaldehyde-13-acetae (287) with MIC of 3.12, 12.5, 25, and 25 μg/ml, respectively, against M. tuberculosis H37Ra by MABA
Successively with petroleum ether, ethyl acetate, chloroform, and methanol
Triterpenes
Arjunolic acid (295) and friedelin (296) which, respectively, had MICs against BCG of 156 μg/ml and 4.9 μg/ml, respectively, by broth microdilution method
Methyl (S)-flavogallonate (297), ellagic acid xyloside (298), and methyl ellagic acid xyloside (299) against M. smegmatis by measured spectrophotometrically at 620 nm
α- and β-Amyrin (300), α-amyrin acetate (301), and dotriacontane (302) with MIC of 31.25, 62.5, and 62.5 μg/ml, respectively, against M. tuberculosis H37Rv (ATCC 27294) by MABA
Friedelin (296), triacontanol (303), β-sitosterol (34), and sitostenone (35) with MIC of 250 μg/ml, 250 μg/ml, 500 μg/ml, and 500 μg/ml, respectively, against M. smegmatis by measured spectrophotometrically at 620 nm
3,4-Di-O-methylellagic acid 3-O-β-D-xylopyranoside (306) and 4-O-galloy-3,3-di-O-methylellagic acid 4-O-β-Dxylopyranoside (307) with MIC of 4.88 μg/ml and 9.76 μg/ml, respectively, against M. tuberculosis H37Rv (ATCC 27294) by MABA
Tetraceranoate (308) and N-hydroxy imidate-tetracerane (309) with MIC of 7.8 μg/ml and 15 μg/ml, respectively, against M. smegmatis (ATCC 23246) by tetrazolium method
Dichloromethane–methanol (1 : 1) followed by a 100% methanol
Steroids
Stigmast-5-en-3β-ol-7-one (310), stigmast-4-ene-6β-ol-3-one (311), stigmast-5,22-dien-3β-ol-7-one (312), and stigmast-4,22-dien-6β-ol-3-one (313) were found to be the most active compounds with MIC of 1.9, 4., 1.0, and 2.2 μg/ml, respectively, against M. tuberculosis by fluorescence assay
Tiliacorinine (314), 2-nortiliacorinine (315), and tiliacorine (316) are bisbenzylisoquinoline alkaloids with MIC of 3.1–6.2 mg/ml against M. tuberculosis different strains by MABA
p-Coumaric acid (317) and 4-hydroxybenzoicacid (318) with MIC 31.3 μg/ml of 62.5 μg/ml against M. tuberculosis H37Rv by high throughput spot culture growth inhibition assay
Decarine (319) and an N-isobutylamide, N-isobutyl-(2E,4E)-2,4-tetradecadienamide) (320) with MICof 1.6 μg/ml against M. tuberculosis H37Rv by measuring the optical density at 600 nm in a Tecan M200 plate spectrophotometer
Hydroxy-1, 3-dimethoxy-10-methyl-9-acridone (321), 3-hydroxy-1, 5, 6--trimethoxy-9-acridone (322) with MIC of 5.1 and 1.5 μg/ml, respectively, against M. tuberculosis H37Rv by MABA
7-[(2E) −3,7-dimethylocta-2,6-dienoxy] −8-methoxychromen-2-one (collinin) (323) with MIC50 of 3.13–6.25 μg/ml against both drug-susceptible and -resistant strains of M. tuberculosis by luminescent viability assay kit
7-Methoxyanodendroate (324), 7-methoxywutaifuranal (325), wutaiensal (326), dictamnine (327), and γ-fagarine (328), with MIC of 35, 35, 30, 30, and 30 μg/ml, respectively, against M. Tuberculosis H37Rv by the agar proportion method
(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-yl linoleate (329), (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-yl oleate (330), and (E)-4-(3,4-dimethoxyphenyl) but-3-en-1-yl palmitate (331),with MIC of 200, 100, and 200 μg/ml, respectively, against M. tuberculosis H37Ra by MABA
3-O-Vanillylceanothic acid (332), betulinaldehyde (333), betulinic acid (334), and 2-O-E-p-coumaryl alphitolic acid (335) with MIC of 25, 25, 25, and 12.5 μg/ml, respectively, against M. tuberculosis H37Ra by MABA